Immunocore Holdings plc
IMCR- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001671927
No open-market purchases or sales by Immunocore Holdings plc insiders were filed in the last 90 days; 135 institutions reported holding it in 13F filings for Q2 2026, worth $1.65B in total; no superinvestor holds it.
13F holders, Q3 2021
Institutional positions in Immunocore Holdings plc as of Sep 30, 2021. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 47
- +2 vs. Q2 2021
- Shares held
- 16.7M
- +2.27M (+15.8%) vs. Q2 2021
- Total value
- $617.4M
- +$56.2M (+10.0%) vs. Q2 2021
- New holders
- 7
- 15 more added
- Sold out
- 5
- 8 more reduced
Compare with Q2 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting IMCR on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 135 | $1.65B |
| Q1 2026 | 142 | $1.58B |
| Q4 2025 | 149 | $1.79B |
| Q3 2025 | 133 | $1.79B |
| Q2 2025 | 134 | $1.50B |
| Q1 2025 | 117 | $1.40B |
| Q4 2024 | 116 | $1.34B |
| Q3 2024 | 130 | $1.41B |
| Q2 2024 | 139 | $1.46B |
| Q1 2024 | 149 | $2.68B |
| Q4 2023 | 133 | $2.56B |
| Q3 2023 | 125 | $1.92B |
| Q2 2023 | 120 | $2.12B |
| Q1 2023 | 109 | $1.61B |
| Q4 2022 | 104 | $1.73B |
| Q3 2022 | 86 | $1.25B |
| Q2 2022 | 66 | $784.5M |
| Q1 2022 | 57 | $590.1M |
| Q4 2021 | 49 | $642.4M |
| Q3 2021 | 47 | $617.4M |
| Q2 2021 | 45 | $561.1M |
| Q1 2021 | 41 | $597.8M |
Institutions, Q3 2021
Shares, value and share of portfolio for each institution holding Immunocore Holdings plc; share changes are against Q2 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Baker Bros. Advisors LP | 2,520,730 | $93.4M | 0.41% | 00.0% | Unchanged |
| Rock Springs Capital Management LP | 2,445,155 | $90.6M | 1.91% | +50,370+2.1% | Added |
| FMR LLC | 2,180,986 | $80.8M | 0.01% | +949,142+77.1% | Added |
| RTW Investments, LP | 1,245,532 | $46.2M | 0.70% | 00.0% | Unchanged |
| Avidity Partners Management LP | 1,095,600 | $40.6M | 1.04% | +494,600+82.3% | Added |
| Wellington Management Group LLP | 1,052,075 | $39.0M | 0.01% | +760,563+260.9% | Added |
| General Atlantic LLC | 950,000 | $35.2M | 0.21% | 00.0% | Unchanged |
| BlackRock Inc. | 827,604 | $30.7M | 0.00% | −252,322−23.4% | Reduced |
| Bain Capital Public Equity Management II, LLC | 638,205 | $23.7M | 0.96% | +163,651+34.5% | Added |
| Bill & Melinda Gates Foundation | 576,923 | $21.4M | 6.26% | 00.0% | Unchanged |
| Perceptive Advisors LLC | 400,000 | $14.8M | 0.22% | 00.0% | Unchanged |
| Price T Rowe Associates Inc | 362,026 | $13.4M | 0.00% | −5,278−1.4% | Reduced |
| Thrivent Financial for Lutherans | 350,214 | $13.0M | 0.03% | +1,400+0.4% | Added |
| Massachusetts Financial Services Co | 335,512 | $12.4M | 0.00% | +238,286+245.1% | Added |
| HHLR Advisors, Ltd.SuperinvestorHHLR Advisors (Hillhouse) | 277,754 | $10.3M | 0.13% | 00.0% | Unchanged |
| Artal Group S.A. | 200,000 | $7.41M | 0.18% | 00.0% | Unchanged |
| First Manhattan Co | 197,999 | $7.34M | 0.03% | +197,999 | New |
| Principal Financial Group Inc | 184,925 | $6.86M | 0.00% | +7,820+4.4% | Added |
| Point72 Asset Management, L.P. | 149,000 | $5.52M | 0.03% | +76,100+104.4% | Added |
| Millennium Management LLC | 93,812 | $3.48M | 0.00% | −9,309−9.0% | Reduced |
| Rhenman & Partners Asset Management AB | 90,000 | $3.34M | 0.23% | 00.0% | Unchanged |
| Pier Capital, LLC | 78,514 | $2.91M | 0.30% | +78,514 | New |
| Samsara BioCapital, LLC | 64,000 | $2.37M | 0.39% | 00.0% | Unchanged |
| Alps Advisors Inc | 53,663 | $1.99M | 0.02% | −3,610−6.3% | Reduced |
| Omega Fund Management, LLC | 51,535 | $1.91M | 0.21% | 00.0% | Unchanged |
| Pura Vida Investments, LLC | 50,000 | $1.85M | 0.14% | +50,000 | New |
| TD Asset Management Inc | 27,506 | $1.02M | 0.00% | 00.0% | Unchanged |
| Legal & General Group Plc | 25,277 | $933.0K | 0.00% | +6,186+32.4% | Added |
| Marshall Wace North America L.P. | 25,144 | $932.0K | 0.00% | 00.0% | Unchanged |
| Citadel Advisors LLC | 22,528 | $835.0K | 0.00% | −28,782−56.1% | Reduced |
| ETF Managers Group, LLC | 16,292 | $603.0K | 0.01% | +3,130+23.8% | Added |
| UBS Group AG | 14,001 | $519.0K | 0.00% | +1,987+16.5% | Added |
| Victory Capital Management Inc | 9,528 | $353.0K | 0.00% | 00.0% | Unchanged |
| Boothbay Fund Management, LLC | 6,826 | $253.0K | 0.01% | +770+12.7% | Added |
| State Street Corp | 6,200 | $230.0K | 0.00% | +6,200 | New |
| Geode Capital Management, LLC | 5,997 | $222.0K | 0.00% | 00.0% | Unchanged |
| Virtus ETF Advisers LLC | 5,359 | $199.0K | 0.09% | −275−4.9% | Reduced |
| Geneos Wealth Management Inc. | 4,250 | $163.0K | 0.01% | +4,250 | New |
| Sphera Funds Management Ltd. | 4,235 | $157.0K | 0.02% | +4,235 | New |
| Zurcher Kantonalbank (Zurich Cantonalbank) | 3,864 | $143.0K | 0.00% | 00.0% | Unchanged |
| Morgan Stanley | 2,321 | $86.0K | 0.00% | +2,301+11,505.0% | Added |
| Bank of America Corp | 2,253 | $84.0K | 0.00% | +2,108+1,453.8% | Added |
| Cubist Systematic Strategies, LLC | 500 | $19.0K | 0.00% | +500 | New |
| State of Wyoming | 143 | $5.00K | 0.00% | −69−32.5% | Reduced |
| Advisor Group Holdings, Inc. | 123 | $4.00K | 0.00% | −6−4.7% | Reduced |
| Harbour Investments, Inc. | 25 | $1.00K | 0.00% | 00.0% | Unchanged |
| Point72 Hong Kong Ltd | 3 | $0 | 0.00% | 00.0% | Unchanged |
| Deerfield Management Company, L.P. (Series C) | 0 | $0 | 0.00% | −360,966−100.0% | Sold out |
| Tybourne Capital Management (HK) Ltd | 0 | $0 | 0.00% | −138,192−100.0% | Sold out |
| J. Goldman & Co LP | 0 | $0 | 0.00% | −16,685−100.0% | Sold out |
| Bank of New York Mellon Corp | 0 | $0 | 0.00% | −12,896−100.0% | Sold out |
| Leonteq Securities AG | 0 | $0 | 0.00% | −1,000−100.0% | Sold out |